540 related articles for article (PubMed ID: 22683307)
1. A review on CXCR4/CXCL12 axis in oncology: no place to hide.
Domanska UM; Kruizinga RC; Nagengast WB; Timmer-Bosscha H; Huls G; de Vries EG; Walenkamp AM
Eur J Cancer; 2013 Jan; 49(1):219-30. PubMed ID: 22683307
[TBL] [Abstract][Full Text] [Related]
2. CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis.
Shi J; Wei Y; Xia J; Wang S; Wu J; Chen F; Huang G; Chen J
Future Oncol; 2014 Apr; 10(5):749-59. PubMed ID: 24799056
[TBL] [Abstract][Full Text] [Related]
3. The axis of evil in the fight against cancer.
Petrushev B; Tomuleasa C; Suşman S; Sorişău O; Aldea M; Kacsó G; Buigă R; Irimie A
Rom J Intern Med; 2011; 49(4):319-25. PubMed ID: 22568277
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 Ligands: The Next Big Hit?
Walenkamp AME; Lapa C; Herrmann K; Wester HJ
J Nucl Med; 2017 Sep; 58(Suppl 2):77S-82S. PubMed ID: 28864616
[TBL] [Abstract][Full Text] [Related]
5. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
Kucia M; Reca R; Miekus K; Wanzeck J; Wojakowski W; Janowska-Wieczorek A; Ratajczak J; Ratajczak MZ
Stem Cells; 2005 Aug; 23(7):879-94. PubMed ID: 15888687
[TBL] [Abstract][Full Text] [Related]
6. The role of CXCL12 in tumor microenvironment.
Meng W; Xue S; Chen Y
Gene; 2018 Jan; 641():105-110. PubMed ID: 29017963
[TBL] [Abstract][Full Text] [Related]
7. CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis.
Mortezaee K
Life Sci; 2020 May; 249():117534. PubMed ID: 32156548
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment.
Scala S
Clin Cancer Res; 2015 Oct; 21(19):4278-85. PubMed ID: 26199389
[TBL] [Abstract][Full Text] [Related]
9. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
Wang J; Loberg R; Taichman RS
Cancer Metastasis Rev; 2006 Dec; 25(4):573-87. PubMed ID: 17165132
[TBL] [Abstract][Full Text] [Related]
10. Role of CXCL12/CXCR4 signaling axis in pancreatic cancer.
Wu PF; Lu ZP; Cai BB; Tian L; Zou C; Jiang KR; Miao Y
Chin Med J (Engl); 2013; 126(17):3371-4. PubMed ID: 24033967
[TBL] [Abstract][Full Text] [Related]
11. The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy.
Zhou Y; Cao HB; Li WJ; Zhao L
Chin J Nat Med; 2018 Nov; 16(11):801-810. PubMed ID: 30502762
[TBL] [Abstract][Full Text] [Related]
12. CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.
Guo F; Wang Y; Liu J; Mok SC; Xue F; Zhang W
Oncogene; 2016 Feb; 35(7):816-26. PubMed ID: 25961926
[TBL] [Abstract][Full Text] [Related]
13. Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell lung cancer tumor proliferation.
Wald O; Izhar U; Amir G; Kirshberg S; Shlomai Z; Zamir G; Peled A; Shapira OM
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1503-12. PubMed ID: 21463876
[TBL] [Abstract][Full Text] [Related]
14. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis.
Tsuboi K; Kodera Y; Nakanishi H; Ito S; Mochizuki Y; Nakayama G; Koike M; Fujiwara M; Yamamura Y; Nakao A
Oncol Rep; 2008 Nov; 20(5):1117-23. PubMed ID: 18949410
[TBL] [Abstract][Full Text] [Related]
15. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
17. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
[TBL] [Abstract][Full Text] [Related]
18. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S
J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600
[TBL] [Abstract][Full Text] [Related]
19. The CXCR4/CXCL12 axis in cutaneous malignancies with an emphasis on melanoma.
Mitchell B; Mahalingam M
Histol Histopathol; 2014 Dec; 29(12):1539-46. PubMed ID: 24879309
[TBL] [Abstract][Full Text] [Related]
20. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
